MAP2K7 and melanoma: The combination of metabolic pathway-related kinase, such as phosphoglycerate dehydrogenase (PHGDH) and pyruvate dehydrogenase kinase (PDK), and MEK inhibitors also inhibited the growth of NRASmut melanoma cells [155,156].